Document is current
Any future updates will be listed below
-
Authors
Brown, Leanne M. https://orcid.org/0009-0002-3940-4064
Hagenson, Ryan A. https://orcid.org/0000-0001-9750-1925
Koklič, Tilen
Urbančič, Iztok https://orcid.org/0000-0003-3603-6585
Qiao, Lu
Strancar, Janez https://orcid.org/0000-0001-8032-132X
Sheltzer, Jason M. https://orcid.org/0000-0003-1381-1323
- License Information
-
More Information
Article History
Received: 8 December 2023
Accepted: 11 September 2024
First Online: 19 September 2024
Competing interests
: J.M.S. has received consulting fees from Merck, Pfizer, Ono Pharmaceuticals, and Highside Capital Management, is a member of the advisory boards of Tyra Biosciences, BioIO, and the Chemical Probes Portal, and is a co-founder of Meliora Therapeutics. J.S., T.K. and I.U. are co-founders of Infinite d.o.o. The remaining authors declare no competing interests.
